Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Umbilical cord injection shows promise for stubborn leprosy ulcers

NCT ID NCT05777213

Disease control Sponsor: Yohanes Firmansyah, dr, MH, MM Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial tested whether an injection made from human umbilical cord cells (called secretome) can help heal chronic skin ulcers in people with leprosy. 27 adults with ulcers that had not healed with standard care received the injection and were followed for 12 weeks. The main goals were to check safety and measure changes in wound size.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

27 people

The number who actually took part.

Started

Jan 2019

Finished

Jan 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Chronic ulcers in Morbus Hansen's patients aged 18-80 years * Not recovering with routine therapy for at least 1 months * Trophic ulcers degrees 2 and 3 * Willing to take part in the study * As well as with the respondent's good health to follow this study. Exclusion Criteria: * Patients who took anticoagulants, * Patients had hypertension * Patients had any staging kidney failure * Patients had a history of blood disorders and pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Leprosy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

leprosy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Leprosy Morbus hansen Trophic ulcer

Contacts and locations

Locations

  • RS Alverno Singkawang

    Singkawang, West Borneo, 79123, Indonesia

  • Sukma Clinic

    Tangerang, Banten, 15810, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.